Coronary Artery Disease
Conditions
Keywords
Blood lipids, percutaneous coronary intervention, lipid lowering treatment
Brief summary
The purpose of the study is to follow the management of blood lipids in patients with planned percutaneous coronary intervention (widening of coronary vessels) in a period from 6 to 10 weeks after the intervention.
Interventions
None listed
Sponsors
Study design
Eligibility
Inclusion criteria
* Male or nonpregnant female * Coronary patient hospitalised for elective PCI * Hypercholesterolaemia defined as LDL-C ≥ 2 mmol/L
Exclusion criteria
* Any chronic inflammatory condition * Chronic anti-inflammatory pharmacotherapy (except low-dose ASA)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum total cholesterol concentration | Week 0 |
| Serum LDL cholesterol concentration | Week 0 |
Secondary
| Measure | Time frame |
|---|---|
| Proportion of patients achieving LDL-C < 2 mmol/L | Once during the time period between Week 6 and Week 10 |
| Proportion of patients achieving total cholesterol < 4 mmol/L | Once during the time period between Week 6 and Week 10 |
| Change of hsCRP levels from baseline | Once during the time period between Week 6 and Week 10 |
Countries
Slovenia